Related Experiment Videos

Remarkable catch-up growth in a boy with steroid-responsive nephrotic syndrome

Acta Endocrinologica. Supplementum
|January 1, 1986
PubMed

Insights

High-dose corticosteroid treatment for nephrotic syndrome can significantly impact growth. Discontinuous therapy, however, allowed for catch-up growth in a pediatric patient, improving final height outcomes.

Area of Science:

  • Pediatric Endocrinology
  • Nephrology
  • Growth and Development

Background:

  • Steroid-responsive nephrotic syndrome requires long-term treatment, often with corticosteroids.
  • Corticosteroids are known to affect growth and skeletal maturation in children.

Observation:

  • A boy with nephrotic syndrome received high-dose corticosteroids from age 4 to 21.5.
  • Continuous corticosteroid therapy for 10 years resulted in significant height reduction (from -0.5 to -4.5 SDS).
  • Skeletal age was retarded, with a notable discrepancy between short bone and carpal bone development.

Findings:

  • Discontinuous corticosteroid treatment, maintaining the total weekly dose, led to rapid catch-up growth.
  • The patient achieved a final height of -1.0 SDS.

Implications:

  • Treatment protocols for pediatric nephrotic syndrome may need adjustment to mitigate growth suppression.
  • Intermittent corticosteroid administration could be a strategy to improve final height in children with chronic conditions.
  • Further research is needed to understand the long-term effects of different corticosteroid dosing schedules on skeletal development.

Related Concept Videos